Jason Brandt, MD
Orthopaedic Surgery · Jonesboro, ARNPI 1952368565
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (40.2%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Smith+Nephew accounts for 91.8% of it on its own, with 33 other manufacturers making up the rest. Reporting peaked in 2024 at $40,253 and has fallen 79.3% since, to $8,352 in 2025. Among orthopaedic surgery clinicians in AR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 304 payments — averaging $341.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$95K
- Stryker$2K
- Conformis, Inc.$2K
- Midsouth Orthopedics Inc.$1K
- Arthrex$679
- Amgen$611
- plus $2K from 28 others
Across 1 payment — averaging $12,350 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$12K
What the payments were for
- Consulting fees$41,73840%
- Speaking & faculty fees$33,78533%
- Travel & lodging$18,35218%
- Food & beverage$9,3739%
- Education$5271%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 149 | $95,301 |
| Stryker | 29 | $2,306 |
| Conformis, Inc. | 12 | $1,663 |
| Midsouth Orthopedics Inc. | 5 | $1,408 |
| Arthrex | 5 | $679 |
| Amgen(2 entities) | 35 | $611 |
| DJO, LLC | 8 | $309 |
| Orthalign Inc | 2 | $163 |
| Trice Medical, Inc. | 1 | $151 |
| Vertex | 6 | $146 |
| Pacira Pharmaceuticals Incorporated | 5 | $141 |
| Johnson & Johnson(2 entities) | 7 | $135 |
| Davol Inc. | 5 | $115 |
| Pacira Therapeutics, Inc. | 5 | $106 |
| Ferring Pharmaceuticals Inc. | 5 | $66 |
| Bioventus LLC | 4 | $61 |
| Heron Therapeutics, Inc. | 1 | $55 |
| AstraZeneca | 2 | $39 |
| Radius Health, Inc. | 2 | $36 |
| Pfizer | 2 | $32 |
| Innovation Technologies Inc | 1 | $32 |
| Organogenesis Inc. | 1 | $31 |
| KARL Storz Endoscopy-america | 1 | $24 |
| Baudax Bio Inc. | 1 | $20 |
| Biowound Solutions, Inc. | 1 | $16 |
| Urgo Medical North America, LLC | 1 | $16 |
| Endo USA, Inc. | 1 | $15 |
| Osiris Therapeutics Inc. | 1 | $15 |
| KCI USA, Inc. | 1 | $15 |
| Convatec Inc. | 1 | $14 |
| Medtronic | 1 | $14 |
| Endo Pharmaceuticals Inc. | 1 | $14 |
| Triad Life Sciences Inc. | 1 | $13 |
| Acera Surgical, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Journey II$97,672
- REAL INTELLIGENCE$63,313
- RI.HIP NAVIGATION$19,035
- OR3O Dual Mobility$14,608
- POLARSTEM$11,823
- HIP7$6,162
- Anthology$6,116
- Tandem$6,076
- Journey II XR$6,075
- JOURNEY II UK$6,075
- Journey II BCS$6,075
- Journey II CR$6,075
- Legion Revision$5,971
- KNEE3 Software$4,828
- JOURNEY$4,710
- Navigation Software KNEE3 3.2 Installer$4,386
- LEGION TKS$4,200
- OR3O$4,200
- POLAR3$4,200
- REDAPT$3,825
How this compares
$103,775 in reported general payments places this provider in the 95th percentile of 168 orthopaedic surgery providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Naloxone Hcl | 61 | $4,217 |
| Gabapentin | 346 | $1,840 |
| Meloxicam | 585 | $1,813 |
| Oxycodone Hcl | 286 | $1,629 |
| Mupirocin | 181 | $1,433 |
| Ondansetron OdtOndansetron | 196 | $1,118 |
| Diclofenac Sodium | 44 | $800 |
| Celecoxib | 56 | $693 |
| Ibuprofen | 26 | $346 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 33 | $333 |
| Prednisone | 126 | $316 |
| Tramadol Hcl | 97 | $250 |
| Methylprednisolone | 31 | $193 |
| Cyclobenzaprine Hcl | 26 | $136 |
| Hydromorphone Hcl | 15 | $75 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Jonesboro
- Brandon ByrdJonesboro$17K
- Aaron WallaceJonesboro$5K
- Benjamin StronachLittle Rock$2.5M
- Charles BarnesLittle Rock$2.1M
- Kenneth MartinLittle Rock$322K
- Wesley CoxFayetteville$309K
- William HefleyNorth Little Rock$306K
- David BumpassLittle Rock$175K
- Lawrence O'MalleyLittle Rock$151K
- Jason SmithLittle Rock$102K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.